Moreover, transwell assays demonstrated that ALYREF overexpression promoted the migration and invasion of ovarian cancer cells (Figs. 1H and EV1G), whereas ALYREF silencing impaired ovarian cancer cell migration and invasion abilities (Figs. 1I and EV1G). This evidence concerns the gene ALYREF and ovarian cancer.